Problem Solving the Philippines: The Outpatient Benefit the UHC Act Promised in Two Years
By Giancarlo Angulo
Section 6(b) of the Universal Health Care Act gave PhilHealth two years to “implement a comprehensive outpatient benefit, including outpatient drug benefit and emergency medical services.” The Act took effect on March 8, 2019, so the first mark was March 8, 2021. Konsulta, YAKAP and GAMOT are the programs people point to as the answer. This post lines up what the circulars say against what the Act asked for, and against what officials and the news said along the way. This is part 4 of 4 in The UHC Series. In part 1 I covered what the Act promises and who delivers it, in part 2 the rules under the Act and the study I could not find, and in part 3 PhilHealth’s money.
TLDR
- Konsulta’s policy is dated January 2020, but no clinic could join until the guidelines of December 2020. Services began in 2021 (1,162 people registered by March 2021). It was a primary care package: consultation, 13 lab tests and 21 drugs, paid to clinics as a yearly capitation.
- The Act’s list of services (the IRR’s Section 6.3) has more items than that. Emergency, outpatient drugs on a large scale, dental, mental health and cancer screening each appeared as separate circulars between 2023 and 2025, after both deadlines. I found nothing for palliative care or biologicals (vaccines, insulin).
- I could not find any PhilHealth document that says the comprehensive outpatient benefit has been completed. PhilHealth’s own circulars call their packages “progressive realization” towards it.
- Dialysis, not primary care, is where the outpatient money goes: hemodialysis was P71.7 billion of the P289.3 billion in claims paid in 2025 (about 25%), against P16.4 billion paid under YAKAP.
- Several headline numbers do not match the circulars. “Empaneled” is the biggest one.
What the Act asked for
Section 6(b): within two years, a comprehensive outpatient benefit, “including outpatient drug benefit and emergency medical services,” following the recommendations of the Health Technology Assessment Council (HTAC). The implementing rules (IRR 6.3) list what it must include: health professionals’ services, diagnostic, laboratory and dental services, personal preventive services, “prescription drugs and biologicals,” and other appropriate services. As I showed in part 2, the IRR counts the two years from its own effectivity (no earlier than October 25, 2021).
How the program grew, by date
| Date | What | Circular |
|---|---|---|
| 2000 | PhilHealth’s first outpatient benefit, the Outpatient Consultation and Diagnostic Package | cited in PC2022-0032 |
| 2012 | Primary Care Benefit 1 for indigent and sponsored members | cited in PC2019-0003 |
| April 2019 | Expanded Primary Care Benefit (EPCB): consultation, screening and drugs for seven conditions | PC2019-0003 |
| January 20, 2020 (signed) | Konsulta policy replaces both. All Filipinos, registered with an accredited clinic. It says “effective January 1, 2020,” but PhilHealth’s own report says it was published February 12 | PC2020-0002 |
| December 2020 | Accreditation rules (signed December 16) and implementing rules: capitation of up to P750 (private) or P500 (public) per registered member, 13 labs, 21 drugs. Pilots in 9 provinces and 2 cities for the first half of 2021 | PC2020-0021, PC2020-0022 |
| March 8, 2021 | The Act’s two-year mark. PhilHealth had 1,162 people registered that month | |
| December 30, 2022 | Konsulta+ framework: a “comprehensive outpatient benefit package” to come | PC2022-0032 |
| 2023 | Outpatient mental health package (October); GAMOT outpatient drug sandbox, P9,000 a year (December) | PC2023-0018, PC2023-0029 |
| May 2024 | Konsulta capitation raised to a P1,700 ceiling; mammogram and ultrasound added | PC2024-0013 |
| December 2024 | First outpatient emergency benefit; preventive oral health | PC2024-0033, PC2024-0034 |
| 2025 | Eye care for children, rehabilitation, cancer screening (July), nationwide GAMOT, P20,000 a year (July), YAKAP launch (July 25) | PC2025-0002, -0003, -0013, -0014, -0017 |
| 2026 | Maternity care outside hospitals; YAKAP and GAMOT standards merged (June) | PC2026-0004, PC2026-0007 |
Konsulta before 2023, from PhilHealth’s own reports
The best dated numbers come from PhilHealth’s quarterly reports to the Governance Commission for GOCCs. They are PhilHealth’s figures, and they have errors I note below.
| End of | Accredited providers | People registered |
|---|---|---|
| March 2021 | 54 | 1,162 |
| June 2021 | 87 | 12,474 |
| September 2021 | 135 | 62,710 |
| December 2021 | 188 | 213,828 |
| March 2022 | 183 | 226,068 |
| June 2022 | 437 | 404,081 |
| September 2022 | 1,243 | 1,697,537 |
| December 2022 | 1,678 | 16,739,839 |
- eKonsulta is not a separate program. The circulars define it as the interim web application clinics use to enter data. It was piloted in Sorsogon in 2021.
- The commitment was 25% of the population registered by the end of 2022, or 27.9 million people. The reported 16.7 million is 60% of that. It is also ten times the September figure, and I found no circular, advisory or news item that explains the jump. I would ask PhilHealth how it was counted before relying on it.
- Rollout. PhilHealth said Konsulta was “rolled out nationwide” in July 2021. At the end of September 2021 it had 135 providers.
- A PhilHealth study of 2021 data in four regions (August 2022) found only 690 people with a recorded first visit out of about 181,000 registered. It also cited an earlier pilot evaluation that reported encoding backlogs and payment delays. I could not find that evaluation.
- Audited books. COA’s audit of 2022 shows Konsulta benefit expense of P22,050 in 2021 and P228.8 million in 2022. That is tiny against 213,828 registrations at the end of 2021. It is not a finding, only a gap I can’t explain.
- Money rules. Capitation was paid 40% for registrants with a first visit and 60% on year-end performance. So “P500 or P750 per registered member” in the press release was a maximum, not a payment per registration.
- News. I found no mainstream coverage of the 2020 policy, and none of provider payment delays or medicine shortages in 2021–2022. Several outlets (PNA, PIA, Manila Bulletin) were blocked for me. In October 2022 PhilHealth’s own spokesperson said the roughly 1,270 enrolled providers were not enough, and in December 2022 a senator called on PhilHealth to implement the “comprehensive outpatient benefit package” fully.
- Konsulta+ (December 23, 2022) is a framework with no benefit table and no rates. It ties itself to Section 6(b) and says PhilHealth would contract exclusively under it for primary care and outpatient services “starting 2025.”
I could not obtain the Board resolutions behind these circulars (No. 2479 of 2019, which expanded primary care to all Filipinos, and No. 2746 of 2022, the sandbox). I also found no DOH memo on Konsulta itself.
Item by item against the Act’s list
“Found” means a PhilHealth circular exists. It does not mean the service is available to you where you live.
| Section 6(a)/(b) and IRR 6.3 item | What I found | Limits worth knowing |
|---|---|---|
| Consultation | Konsulta, which grew into YAKAP | You must register with a clinic and have a first visit. Private clinics may charge up to P900 a year; public clinics may charge nothing for covered services |
| Laboratory and diagnostics | 15 listed tests; six cancer-screening tests | The lists are closed. Tests outside them have no outpatient benefit I could find |
| Prescription drugs | GAMOT: 75 listed drugs | P20,000 a year, fixed prices per item, prescribed through the GAMOT app by authorized physicians |
| Emergency services | Outpatient Emergency Care Benefit; ambulance case rates | Patient must be discharged within 24 hours of arriving in the emergency room. Excludes emergency care at home |
| Dental | Preventive oral health only | P1,000 per year; two visits; emergency tooth extraction |
| Mental health | Outpatient package, P9,000 general and P16,000 specialty a year | The package does not pay for the medicines |
| Preventive | Inside Konsulta/YAKAP; cancer screening | No PhilHealth-paid outpatient vaccine benefit found |
| Rehabilitative | Physical medicine and assistive devices (2025) | Needs a physiatrist’s assessment |
| Palliative | Not found | |
| Biologicals | Not found | The GAMOT list has no vaccine or insulin entry |
The table follows the Act’s list, but reading every circular turned up outpatient packages that do not fit it neatly (dates are listing dates). An outpatient HIV/AIDS treatment package rests on a 2009 Board resolution and was last revised on December 22, 2021 (PC2021-0025). A package for secondary prevention of rheumatic fever and rheumatic heart disease was listed on July 12, 2019 (PC2019-0005). Outpatient therapeutic care for severe acute malnutrition in children 60 months and below followed on August 8, 2024 (PC2024-0017). Outpatient hemodialysis was covered up to 144 sessions in circulars for 2020 and 2021 (PC2021-0002, PC2021-0009) and 156 sessions from 2023. COVID-19 testing, community isolation and home isolation packages ran from 2020 to 2022. The emergency benefit was revised on October 31, 2025 (PC2025-0020) and extended to ambulance service on November 12, 2025 (PC2025-0022). I found no palliative or hospice benefit in any circular, and no PhilHealth-paid outpatient vaccine or insulin benefit.
Karl Garcia covers the mental health package, with the same P9,000 and P16,000 figures, in Mental Health as National Infrastructure. He asks whether the benefit is usable outside major cities, a question the circulars cannot answer.
One fairness point that cuts the other way: the 2020 circulars already listed consultation, 13 labs and 21 drugs, and the first clinics registered people in 2021, so some of the benefit was running by the Act’s mark (very thinly) and before the IRR’s. What came later, after both deadlines, was the rest of the IRR’s list.
What was said, and what the documents show
I checked 49 claims from PhilHealth releases and news reports against the circulars and PhilHealth’s own data. Of those, 18 were supported, 12 partly, 4 not supported, and I could not check 15. The ones that matter most:
- “Empaneled.” PhilHealth said 26.75 million Filipinos were empaneled in January 2026 and that YAKAP was “reaching” 33.2 million in May. The circular (PC2025-0017) defines empanelment as coming after a first patient encounter and a signed agreement. PhilHealth’s own statistics show 40.0 million registrations at the end of 2025, but only 14.7 million with a first encounter. At June 30, 2026 the registered figure was 27.2 million, lower than the 33.2 million claimed six weeks earlier.
- “Free medicines for every Filipino.” Everyone is eligible. But getting the medicine needs registration, a first encounter, a prescription from an authorized physician through the GAMOT app, one of the 75 listed drugs, and staying within P20,000.
- Free lab tests. GMA reported 13 and VERA Files reported about 20. The 2024 circular lists 15. The number 13 matches the 2020 list.
- P1,700 “per patient seen.” The circular sets a ceiling per registered member with a first encounter: P680 up front and P1,020 tied to year-end targets.
- How much GAMOT is used. PhilHealth’s 2025 financial statements show P50.7 million of GAMOT spending, about 0.016% of its benefit expense. GAMOT providers went from 41 in Metro Manila (September 2025) to 2,983 on PhilHealth’s July 2026 list. I found no data on how many people used it.
- eKonsulta. An advisory set it to shut down on July 1, 2026. A later one, signed June 30, 2026, keeps it running to December 31 for clinics that have not moved to a new system. The vendor who said so was right.
On what went wrong, officials and the news agree on some points. PhilHealth itself acknowledged in February 2026 that members had trouble getting GAMOT prescriptions at some clinics, and set a readiness checklist for clinics. I did not find reports of delayed payments to clinics, pharmacy arrears or doctors dropping out, and I found no COA audit findings on YAKAP or GAMOT. That means I did not find them, not that they do not exist.
Money
The Act ties outpatient benefits to the lowering of out-of-pocket costs. PSA’s national health accounts put households’ share of current health spending at 41.2% in 2025, from 44.4% in 2023 (see part 3). At a Senate briefing on September 4, 2026, PhilHealth president Beverly Ho called 37% by 2028 the realistic target. None of those statements separates outpatient care, and I found no document that links YAKAP or GAMOT to the target.
How big is primary care in the whole country? PSA’s national health accounts put primary health care spending from all payers at P863.8 billion in 2025, which is 49.8% of current health spending. That share was 55.0% in 2023 and 54.0% in 2024 (both revised). In the same two years PhilHealth’s claims paid more than doubled (see part 3). I am not claiming one caused the other. For scale, PhilHealth’s YAKAP and Konsulta benefit expense was P14.6 billion in 2025, about 1.7% of that national total. The two numbers are on different bases (PhilHealth’s accrued benefit expense against PSA’s spending by all payers, including households and local governments), so read it as an order of magnitude, not a ratio. PSA’s primary care total includes out-of-pocket payments and government facilities, so PhilHealth’s capitation is a small part of it.
Where the outpatient money actually goes. Dialysis is an outpatient service, and it dwarfs everything above. PhilHealth’s Stats and Charts 2025 lists the hemodialysis procedure first among paid claims: P71.7 billion for 7.2 million claims, out of P289.3 billion paid in 2025. That is about 25% of the amount and 38% of the claims (my arithmetic). PhilHealth president Beverly Ho said the same in October 2026: “Twenty-five percent of what we spend in terms of payout goes to dialysis,” roughly P100 billion of P400 billion in total disbursement (Manila Times, October 3, 2026). Her base (disbursement) differs from the claims total (claims paid), and PhilHealth’s 2025 financial statements show benefit expense of P323.6 billion. She used it to argue for primary care: early treatment of hypertension and diabetes could prevent kidney disease. Against that, YAKAP claims paid were P16.4 billion in 2025 (Stats and Charts; the financial statements show P14.6 billion of benefit expense for YAKAP and Konsulta) and GAMOT P50.7 million.
The statistics do not separate outpatient from inpatient claims, so I can’t say what share of all outpatient spending goes to dialysis. The jump is real in the same series. PhilHealth’s own Stats and Charts show hemodialysis claims paid at P12.6 billion in 2020, P17.4 billion in 2022 and 2023, P28.2 billion in 2024 (5.2 million claims, the figure the news reported) and P71.7 billion in 2025. That is 2.5 times 2024, while all claims paid rose 76% (P164.5 billion to P289.3 billion), so dialysis went from 17% to 25% of the total. Claims rose 39%, so the average per claim went from about P5,400 to P9,900. The documents show the session rate itself rising: P2,600 when 156 sessions a year were introduced (PC2023-0009, June 2023), P4,000 in July 2024 (PC2024-0014) and P6,350 in September 2024 (PC2024-0023), up 144% in about fifteen months. Circulars for 2020 and 2021 allowed 144 sessions. Those changes point the same way as the per-claim rise, but I cannot say how much of it they explain, because the statistics do not say how a claim is counted against sessions, and I could not find a PhilHealth explanation. The first half of 2026 shows P48.7 billion.
How I could be wrong
- I searched the full text of every PhilHealth circular listed on its archive pages for 2019 to 2026 (197 circulars), not only titles, and read the hits in context. It is a search, not a line-by-line reading of every page, and for 21 long scanned documents I read only the first 15 pages. A benefit could still sit in a circular that uses none of the words I searched for. The list and results are in the project repo.
- Some figures come from scanned circulars read by OCR (text recognition). I checked these against page images of the PDFs: the P9,000 GAMOT sandbox limit (PC2023-0029), the hemodialysis rates of P2,600, P4,000 and P6,350 and the 156 sessions (PC2023-0009, PC2024-0014, PC2024-0023), the P1,000 preventive oral health maximum with two visits (PC2024-0034) and the 24-hour limit in the emergency benefit (PC2024-0033). I had already checked the P1,700, P900, P20,000 and 75-drug figures against the documents. The mental health amounts (P9,000 and P16,000) and the P750 and P500 capitation ceilings come from circulars with a text layer. I have not re-checked the 15-test and six-test lists against page images.
- Dates are the dates PhilHealth listed the circulars, not when benefits actually started to be paid.
- I could not read several news pages (blocked sites), and I used only search snippets for those claims.
- I could not find whether the HTAC was ever set up or whether it recommended an outpatient benefit. The circulars cite PhilHealth Board resolutions instead. That could mean it does not exist, or that I didn’t find the record.
- “Comprehensive” is a judgment. The Act does not define it, and PhilHealth may argue the packages already add up to it. I found no PhilHealth statement saying so.
- I’m not a lawyer or a health economist. If I got a circular or number wrong, please comment.
What I’d like to do next
Section 6(b) has no number attached, so “done” is a judgment. I would use three tests. The first can be checked today.
- Every item on the IRR’s list has a paid benefit. On what I found, palliative care and biologicals (vaccines, insulin) do not, and dental is preventive only.
- A stated share of outpatient visits is covered. I can’t test this. PhilHealth publishes registrations and first visits, not outpatient visits by who paid.
- The out-of-pocket outpatient share falls. I can’t test this either. PSA’s out-of-pocket share covers all health spending, not outpatient care alone.
Whichever test you prefer, the data needed are the same: people with a first visit (not registrations), GAMOT users, and spending by benefit, published every quarter. I would ask PhilHealth for those three before anyone calls the benefit done.
Sources
- Republic Act No. 11223 (Section 6)
- Implementing Rules and Regulations (Sections 6.1 to 6.3, 34, 41.7)
- PhilHealth circulars: PC2019-0003, PC2020-0002, PC2020-0022, PC2022-0032, PC2023-0018, PC2023-0029, PC2024-0013, PC2024-0033, PC2024-0034, PC2025-0013, PC2025-0014, PC2025-0017, PC2026-0007; advisories: PA2025-0077, PA2026-0003, PA2026-0018, PA2026-0038
- PhilHealth press releases: YAKAP launch (July 25, 2025); February 12, 2026; May 15, 2026
- GMA News: free medicines under YAKAP (March 12, 2026); GMA News: YAKAP 2.0 (September 2, 2026)
- Philstar: Konsulta capitation raised (March 14, 2024)
- VERA Files (October 10, 2025)
- Philstar: 800 private hospitals (March 13, 2026)
- Manila Times: “PhilHealth: 25% of payouts go to dialysis” (October 3, 2026)
- PhilHealth Stats and Charts 2023, 2024 and 2025; Financial Statements, December 31, 2025 (note 28); PSA National Health Accounts (see part 3)
- Karl Garcia: Mental Health as National Infrastructure (August 28, 2026)
- PhilHealth quarterly monitoring reports to the Governance Commission for GOCCs, 2020–2022; PhilHealth rapid evaluation of Konsulta (August 2022); COA annual audit report on PhilHealth, 2022
Corrections and updates
I checked this post against more circulars and PhilHealth’s own reports. Each correction is dated. The text above is unchanged.
- October 24, 2026. PhilHealth does pay for an outpatient vaccine. The TLDR, the “Preventive” row and the “Biologicals” row say I found no PhilHealth-paid outpatient vaccine benefit. That is wrong. Since PhilHealth Circular No. 15, s. 2012, PhilHealth has paid a fixed P3,000 per case for animal-bite treatment, which covers rabies vaccine, rabies immune globulin, tetanus toxoid and anti-tetanus serum. In Stats and Charts 2025 (p. 15), Animal Bite is the third-largest paid procedure: P3.04 billion for about 546,000 claims. What I did not find is a benefit for routine immunization or for maintenance insulin.
- October 24, 2026. Palliative care is not on the IRR 6.3 list. The first of my three tests asks whether “every item on the IRR’s list has a paid benefit” and names palliative care. The IRR’s Section 6.3 list is the one I give earlier in this post: professionals’ services, diagnostic, laboratory and dental services, personal preventive services, “prescription drugs and biologicals” and other appropriate services. Palliative care comes from the Act’s Section 6(a), and the IRR deals with it in Section 6.1. So the test should read “every item on the IRR’s 6.3 list”, and palliative care is a separate gap.
- October 24, 2026. PhilHealth does call Konsulta a comprehensive outpatient benefit. I wrote that I found no PhilHealth statement saying the benefit is comprehensive. Stats and Charts 2024 (p. 18) says the Konsulta benefit package “is a comprehensive outpatient benefit as mandated by the Universal Health Care Law”. A note to PhilHealth’s audited 2025 financial statements says that since January 1, 2025 PhilHealth “has introduced” new packages including “a Comprehensive Outpatient Benefit Package”. I still found no PhilHealth document that says Section 6(b) has been fully met.
Sources: PhilHealth Stats and Charts 2025 and 2024; COA’s 2025 audit report on PhilHealth.
The UHC Series
Problem Solving the Philippines: The UHC Series.
- Part 1: What the Universal Health Care Act promises, and who has to deliver it
- Part 2: The study I can’t find, and the rules under the Act
- Part 3: Whose money? The PhilHealth reserve rule, the Supreme Court and the numbers
- Part 4: The outpatient benefit the Act promised within two years (this post)
Lovingly made with Claude.
Comments
14 Responses to “Problem Solving the Philippines: The Outpatient Benefit the UHC Act Promised in Two Years”Trackbacks
Check out what others are saying...-
[…] Part 4: The outpatient benefit the Act promised within two years […]
-
[…] Part 4: The outpatient benefit the Act promised within two years […]
-
[…] Part 4 looks at the outpatient benefit the Act promised within two years. […]
this may help for those looking for cheaper gamot. but in the end, there is no such thing as free lunch, and the pamabansang botika is looking for entrepreneurs willing to franchise with them. I dont know if big brand pharmas protective of their turf will challenge the pambansang botika trend, but if they are business savvy they will probly incorporate pambansang botika, and apply for franchise.
towards the end of president bong marcos’s term, it is envisaged there will be thousands of pambansang botika franchisees all over the philippines.
https://www.abs-cbn.com/news/business/2026/9/29/-pambansang-botika-launched-open-for-franchise-2046
this is one of the issues that takes a lot of money to solve because of our geography and the cost of logistics. When there is a watson’s or mercury drug nearby it is not an issue as the population is big enough to support. There is a common term in Phil Government planning which is GIDA (Guidance-Note-on-Identifying-Geographically-Isolated-Disadvantaged-Areas-GIDA-in-Pantawid-Pamilyang-Pilipino-Program.pdf). These places usually are so uneconomical to serve.
I find the rigor of the assessment impossible to navigate, and I have an advanced college degree. If armed conflict is a qualifier, it’s useless. It’s an administrative nightmare to manage. There must be a simpler way.
My experience is that pharmacies here are pragmatic and will give customers the benefit of the doubt on prescriptions. loosey goosey, I suppose, because data are not recorded anywhere. Paper pushing.
heto po, sorry, I’m too lazy to summarise kaya here’s the whole shebang:
AI Overview
The Philippines addresses pharmaceutical and medical supply shortages in its most remote villages—officially designated as Geographically Isolated and Disadvantaged Areas (GIDAs)—through a mixture of decentralization, workforce deployment, regulatory flexibility, and community-driven initiatives. Scribd +1
Because the country consists of over 7,000 islands, delivering healthcare presents massive logistical hurdles. The government and private sectors utilize several core strategies to bypass these barriers: YouTube·CNA Insider
1. Decentralization and Localized Distribution Hubs
Under the Universal Health Care (UHC) Act, the Philippines is moving toward a more decentralized model to prevent logistics bottlenecks in Manila. National Institutes of Health (NIH) | (.gov) +1
2. Regulatory Flexibility: The Telepharmacy Sandbox
The Philippines faces a severe shortage of rural pharmacists. To solve this, the Food and Drug Administration (FDA) and the private sector launched a Regulatory Sandbox Pilot Program running from late 2025 through 2027.
3. Frontline Personnel and the “Doctors to the Barrios” Program
Medicines cannot be distributed safely without healthcare personnel to prescribe and manage them.
4. Expansion of Free Outpatient Medicine Outlets
Financing is a major barrier to access, as poor families often cannot afford the travel costs to buy medicine. Through the PhilHealth Gamot (Guaranteed and Accessible Medications for Outpatient Treatment) program, the state health insurance system has expanded coverage to dozens of essential medication types. Patients can access these for free up to a designated cap at accredited rural outpatient clinics.
5. Telemedicine and Tech-Driven Care
Apps like mWell and NowServing partner with local organizations to establish telehealth kiosks in remote areas. Local health workers connect patients with remote specialists who generate digital prescriptions. These digital scripts can then be fulfilled by municipal health offices or local community partners.
The Informal Bridge: Sari-Sari Stores
Despite formal interventions, systemic gaps remain—leaving many remote citizens more than an hour away from an actual pharmacy. Studies by institutions like the University of the Philippines and Ateneo de Manila University highlight that neighborhood sari-sari stores (small micro-convenience shops) frequently act as informal pharmacies. While the government discourages the un-prescribed sale of regulated drugs here due to counterfeit risks, policymakers are actively studying how to safely integrate these ubiquitous neighborhood stores as legitimate, closely monitored access points for basic over-the-counter medicine.
I have three observations.
Thanks for the effort you put into this report. it’s the kind of management professionalism PhilHealth can’t seem to find.
Thank you for the kind words. If people like you and joey can contribute so much we have an obligation as people here to do our part.
Way off topic but interesting, as I go through the news. Toyota now produces modern jeepneys in the Philippines. My only complaint is that the paint job needs to be jazzed up properly, and there aren’t enough lights and horns. The good news is that if it is designed to hold 11, it will hold 20 in actual use. 🙂
https://www.abs-cbn.com/news/business/2026/10/13/toyota-unveils-tamaraw-modern-jeepney-1445
much like ferries, they have specific number of passengers to take, but ferry captains push their luck and take on more passengers than allowed. some ferries end up in disaster, overloaded and capsized even in good weather. likewise, jeepneys taking on more passengers than ought to, need be concern of safety for everyone. too much sabit can cause accident and drivers may lose license.
Overall the outpatient provisions of PhilHealth seem very popular with urban acquaintances. They all rush to register and recognize the value of paying into PhilHealth. Many have paid voluntary contributions for their parents (who haven’t had consistent work, like ever) in order to access maintenance medications.
Outside of cities, acquaintances there don’t yet know the benefits of PhilHealth. About 2 hours from Dumaguete, a family I know lost a lolo, a ka-live-in, and an uncle in the span of 5 years from preventable disease simply because they were afraid to access healthcare. Last week, the lady’s ka-live-in died from occupational lung cancer which was too advanced by the time he could not handle the sakit anymore and relented on going to Dumaguete to gather the opinion of a specialist. Even if they had wanted to enroll in PhilHealth, there are no doctors and clinics in their communities that regularly take PhilHealth to begin with. So an expansion of provider enrollment and educational program might be useful.
I recall Filipinos being on the thinner side when I first visited in 1998 (they called me “fat” in an admiring way, but I was quite fit and played football in high school). Since then I have been noticing many more Filipinos developing health issues such as diabetes. Hemodialysis centers similar to in the US operating on an exclusive model of the US “free dialysis” mandate probably will start popping up soon in the Philippines. Hemodialysis carries a heavy cost to the US taxpayer; as a percentage in relation to the Philippine GDP the cost borne on the Philippines is much higher. Many Filipinos, especially in Class DE, still push off treatment until the last minute then expect prescribed pills to cure their ailments. Not only is this risking a less desirable health outcome, but places a bigger burden on both the patient and the system. Wherever possible, preventable care must be expanded and the people educated on their ability to access such care.
really, joey, d and e in the philippines even the poorest of the poor have access to cell phone, more access than sanitary toilets! more than 80 per cent have access to cell phone, hence it is easy for them to access philhealth online instead of tiktoking and instagraming. though both tiktok and instagram may provide philhealth info. the obvious case for their poor health is that most cannot be bothered to consult even online, and many will not take time off work, putting their health on the back burner, ignoring health issues until the last minute, and praying for miracles that may only offer false hope. many soon realize that are not like cats with nine lives.
health centers are open even in remote places, visiting medical officers travel from barrio to barrio in their medivans. and all the poor have to do is to make appoint and front up, take their turn and wait for service. but if they want door to door service, that is different story.
I must confess I have an irrational fear of checkups